Kutzkey Tim

CIK 00016141868 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001614186

Recent Transactions

50 trades

Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2026-01-20$19.60/sh+8,484→ 900,292 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2026-01-20$19.60/sh+9,568→ 1,016,658 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2026-01-16$20.00/sh+1,204→ 891,808 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2026-01-16$20.00/sh+1,358→ 1,007,090 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2026-01-15$19.89/sh+5,590→ 890,604 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2026-01-15$19.89/sh+6,303→ 1,005,732 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2026-01-06$19.89/sh+7,097→ 876,557 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2026-01-06$19.89/sh+8,003→ 989,893 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2025-12-05$19.54/sh+16,381→ 981,890 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2025-12-05$19.54/sh+14,503→ 869,460 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2025-12-04$17.35/sh+2,791→ 965,509 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2025-12-04$17.35/sh+2,475→ 854,957 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2025-11-13$12.65/sh+148,150→ 852,482 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2025-11-13$12.65/sh+167,307→ 962,718 total
Award
Surrozen, Inc./DE$SRZN
Option (right to buy)
2025-03-26+2,666→ 2,666 total
Other
RAPT Therapeutics, Inc.$RAPT
Common Stock
2024-12-23−1,599,417→ 0 total
Other
RAPT Therapeutics, Inc.$RAPT
Warrant (right to purchase)
2024-12-23+1,352,008→ 1,352,008 total
Other
RAPT Therapeutics, Inc.$RAPT
Common Stock
2024-12-23−1,352,008→ 50,000 total
Other
RAPT Therapeutics, Inc.$RAPT
Warrant (right to purchase)
2024-12-23+1,599,417→ 1,599,417 total
Award
Surrozen, Inc./DE$SRZN
Option (right to buy)
2024-06-05+1,333→ 1,333 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−858,035→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−15,000→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−100,000→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−1,298,908→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−2,265,758→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−968,990→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−11,103,333→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−90,442→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−44,000→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−100,000→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−2,650,177→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−949,862→ 0 total
Other
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05+1,000→ 1,000 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−1,298,908→ 0 total
Purchase
Surrozen, Inc./DE$SRZN
Series A Common Warrants
2024-04-04+90,897→ 90,897 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2024-04-04$15.50/sh+102,651→ 326,992 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2024-04-04$15.50/sh+90,897→ 289,549 total
Purchase
Surrozen, Inc./DE$SRZN
Series D Common Warrants
2024-04-04+397,773→ 397,773 total
Purchase
Surrozen, Inc./DE$SRZN
Series D Common Warrants
2024-04-04+352,225→ 352,225 total
Purchase
Surrozen, Inc./DE$SRZN
Series C Common Warrants
2024-04-04+397,773→ 397,773 total
Purchase
Surrozen, Inc./DE$SRZN
Series B Common Warrants
2024-04-04+111,656→ 111,656 total
Purchase
Surrozen, Inc./DE$SRZN
Series A Common Warrants
2024-04-04+102,651→ 102,651 total
Purchase
Surrozen, Inc./DE$SRZN
Series B Common Warrants
2024-04-04+98,870→ 98,870 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2024-04-04$15.50/sh+90,897→ 294,767 total
Purchase
Surrozen, Inc./DE$SRZN
Common Stock
2024-04-04$15.50/sh+102,651→ 332,885 total
Purchase
Surrozen, Inc./DE$SRZN
Series C Common Warrants
2024-04-04+352,225→ 352,225 total
Purchase
NGM BIOPHARMACEUTICALS INC
Common Stock
2023-11-16$0.62/sh+5,840→ 949,862 total
Purchase
NGM BIOPHARMACEUTICALS INC
Common Stock
2023-11-15$0.71/sh+16,791→ 944,022 total
Award
Surrozen, Inc./DE$SRZN
Option (right to buy)
2023-05-18+20,000→ 20,000 total
Purchase
NGM BIOPHARMACEUTICALS INC
Common Stock
2023-01-31$5.00/sh+176,730→ 927,231 total

Companies

Recent Filings

Address

C/O SURROZEN, INC. 171 OYSTER POINT BLVD., SUITE 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov